These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17630868)

  • 21. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Datapoints: prescription patterns for mood and anxiety disorders in a community sample.
    Mojtabai R
    Psychiatr Serv; 1999 Dec; 50(12):1557. PubMed ID: 10577871
    [No Abstract]   [Full Text] [Related]  

  • 23. Many Young Children with Autism Who Use Psychotropic Medication Do Not Receive Behavior Therapy: A Multisite Case-Control Study.
    Wiggins LD; Nadler C; Rosenberg S; Moody E; Reyes N; Reynolds A; Alexander A; Daniels J; Thomas K; Giarelli E; Levy SE
    J Pediatr; 2021 May; 232():264-271. PubMed ID: 33493493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychotropic drug use among 0-17 year olds during 2004-2014: a nationwide prescription database study.
    Hartz I; Skurtveit S; Steffenak AK; Karlstad Ø; Handal M
    BMC Psychiatry; 2016 Jan; 16():12. PubMed ID: 26822371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychotropic medication utilization at a group-home residential facility for children and adolescents.
    Handwerk ML; Smith GL; Thompson RW; Spellman DF; Daly DL
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):517-25. PubMed ID: 18928416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychotropic medication use in French children and adolescents.
    Kovess V; Choppin S; Gao F; Pivette M; Husky M; Leray E
    J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):168-75. PubMed ID: 25584837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacoepidemiology of obsessive-compulsive disorder: A Swedish nationwide cohort study.
    Isomura K; Nordsletten AE; Rück C; Ljung R; Ivarsson T; Larsson H; Mataix-Cols D
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):693-704. PubMed ID: 26922101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of prescription of psychotropic drugs for older patients in a general hospital.
    Arnold I; Straube K; Himmel W; Heinemann S; Weiss V; Heyden L; Hummers-Pradier E; Nau R
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):76. PubMed ID: 29202811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychotropic medications prescribing patterns for children and adolescents in New York's public mental health system.
    Lyons JS; MacIntyre JC; Lee ME; Carpinello S; Zuber MP; Fazio ML
    Community Ment Health J; 2004 Apr; 40(2):101-18. PubMed ID: 15206636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiling psychotropic discharge medication from a children's psychiatric ward.
    Akram G
    Int J Clin Pharm; 2015 Oct; 37(5):753-7. PubMed ID: 25893488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood.
    Brinker A; Mosholder A; Schech SD; Burgess M; Avigan M
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):328-33. PubMed ID: 17630866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. State variation in psychotropic medication use by foster care children with autism spectrum disorder.
    Rubin DM; Feudtner C; Localio R; Mandell DS
    Pediatrics; 2009 Aug; 124(2):e305-12. PubMed ID: 19620187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany.
    Bachmann CJ; Manthey T; Kamp-Becker I; Glaeske G; Hoffmann F
    Res Dev Disabil; 2013 Sep; 34(9):2551-63. PubMed ID: 23747941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescribing of psychotropic drugs to children and adolescents.
    Adams S
    BMJ; 1991 Jan; 302(6770):217. PubMed ID: 1998763
    [No Abstract]   [Full Text] [Related]  

  • 35. Increase in Psychoactive Drug Prescriptions in the Years Following Autism Spectrum Diagnosis: A Population-Based Cohort Study.
    Croteau C; Mottron L; Presse N; Tarride JE; Dorais M; Perreault S
    J Popul Ther Clin Pharmacol; 2017 Aug; 24(3):e19-e32. PubMed ID: 28873291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescription patterns of psychotropic medications for the treatment of psychotic disorders in the largest mental health institutions of Uganda.
    Rukat A; Musisi S; Ströhle A; Mundt AP
    J Clin Psychopharmacol; 2014 Oct; 34(5):571-6. PubMed ID: 24943390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotropic drug prescribing for hospitalized patients with acquired immunodeficiency syndrome.
    Ochitill H; Dilley J; Kohlwes J
    Am J Med; 1991 May; 90(5):601-5. PubMed ID: 2029017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Side effects associated with psychoactive medication in individuals with autism.
    Aman MG; Van Bourgondien ME; Osborne PW; Sarphare G
    J Autism Dev Disord; 1997 Jun; 27(3):342-4. PubMed ID: 9229265
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of psychotropic drugs and analgesics among users of antiobesity drugs--a population based study.
    Amundsen MO; Engdahl B; Berg C; Nordeng H
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):273-9. PubMed ID: 20014050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychiatric diagnosis and psychotropic medication prescription patterns in a mental hospital-based child and adolescent psychiatric service in Nigeria.
    Bakare MO; Igwe MN; Odinka PC; Iteke O
    J Health Care Poor Underserved; 2011 Aug; 22(3):751-5. PubMed ID: 21841276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.